HHMI
ABEV icon

Howard Hughes Medical Institute’s Ambev ABEV Stock Holding History

Howard Hughes Medical Institute’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-49,784
Closed -$304K – 157
2015
Q2 		$304K Sell
49,784
-21,445
-30% -$133K 0.06% 113
2015
Q1 		$410K Buy
+71,229
New +$442K 0.06% 106

Other funds holding ABEV

VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GTP
Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Howard Hughes Medical Institute's ABEV Position: Q3 2015 in Review

Howard Hughes Medical Institute sold out of Ambev (ABEV) in Q3 2015, closing a stake of 49,784 shares — an estimated $304K sold.

Howard Hughes Medical Institute first reported a position in ABEV in Q1 2015 and held it in 2 quarters. The position peaked at $410K in Q1 2015. 301 funds tracked by Wall St. Rank hold ABEV as of Q3 2015.

  • Howard Hughes Medical Institute reported no remaining Ambev position as of Q3 2015 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 49,784 Ambev shares in Q3 2015, an estimated $304K.
  • Howard Hughes Medical Institute first reported a position in Ambev in Q1 2015 and held it in 2 quarters.
  • Howard Hughes Medical Institute's Ambev position peaked at $410K in Q1 2015.
  • 301 funds tracked by Wall St. Rank held Ambev as of Q3 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2015, filed 16 Nov 2015.